Selexis Corporate Overview Q1 2019
January 22, 2019
Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines.
TRUST-INDEX® EMPLOYEE SURVEY
June 14, 2018
Trust develops when credibility, respect and fairness thrive in a workplace. A culture of trust gives rise to camaraderie and pride. The survey uses 58 closed questions in the Trust-Index employee survey to find out how employees see the following dimensions in their company….
Selexis Corporate Overview Q3 2017
September 29, 2017
Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell-line generation, providing unparalleled proprietary technology and the highly specialized expertise necessary to translate scientific innovation into life-saving medicines for patients.
Selexis Customer Survey Q2 2017
August 4, 2017
In 2017, Selexis surveyed our partners to collect feedback and gain insight about our company and technology. With our partners’ insights, we can build upon our business, continue to advance our technology and enhance our overall partner experience.
JSR Life Sciences, KBI Biopharma, Selexis Overview
June 21, 2017
The Contract Development Manufacturing Organization of the 21st Century Combined Forces to Serve as the Biopharmaceutical Customer- and Patient-Focused CDMO with the Most Robust and Fastest “Gene to GMP” Service Offering in the Industry
The new European data protection law requires us to inform you of the following before you use our website: